Horizon Discovery Group PLC (LSE:HZD) - Share price - Overview

Stock Report

Horizon Discovery Group PLC HZD

Last Price
GBX225.00

Day Change
-3.00|-1.32%

As of 22/11/2017
17:15:00 GMT | GBX
Minimum 15 Minutes Delay.

Last Close228.00p
Day Range225.00 - 239.75
Mkt Cap339.50Mil
52-Wk Range104.00 - 297.70
Yield %0.00
ISINGB00BK8FL363
Volume156,841
P/E-20.97
P/S8.84
P/CF-26.22

Share Price

Total Returns 22/11/2017

 Chg (%)  
More ...
Horizon Discovery Group PLC-12.11 
FTSE 100 TR GBP-1.04
 
Financials
201420152016
More ...
Income Statement
Turnover11.9120.1624.07
Operating Profit-6.11-10.29-12.36
Net Profit-5.92-9.88-11.43
Reported EPS-9.20-11.20-12.10
Balance Sheet
Current Assets25.8136.5120.59
Non Current Assets39.9352.3666.81
Total Assets65.7488.8787.40
Current Liabilities5.876.788.70
Total Liabilities7.179.019.51
Total Equity58.5779.8677.89
Cash Flow
Operating Cash Flow-6.62-11.08-8.52
Net Change in Cash14.276.60-19.37
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
2017-6.09-4.29--53.21---
2018-1.12-0.43--525.35---
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
07/08/2017Exercise of OptionDr. Darrin Disley165.6010,86917,999.00
07/08/2017Exercise of OptionMr. Richard Vellacott165.6010,86917,999.00
02/12/2016PurchaseDr. Darrin Disley117.0025,00029,250.00
02/12/2016PurchaseMr. Richard Vellacott117.0010,00011,700.00

Company Profile

Horizon Discovery Group PLC is one of the leading medical technology companies in the United Kingdom. Its activities mainly include the application of gene editing and building cells that harbor the genetics of human disease.

Sector

Biotechnology

Market Position

565 of 1833 Companies

Index

FTSE AIM 100 ,FTSE AIM All Share

Outlook

(26/09/2017) "...the board is confident in the group's future prospects and Horizon looks forward to a strong performance in the second half of the year and beyond"

Next Event 31/12/2017

Next year end (to be reported)
Ratios
CompSecMkt
More ...
PER (E)-266.3513.5616.21
Div Yld (E)0.004.134.24
PEG (E)0.001.391.19
ROCE-41.43181.6816.16
Op Mrgn-44.59-8.11-8.91
EPS Grwth0.0012.2014.08
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy2
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanDr. Ian Gilham
Chief Executive OfficerDr. Darrin Disley
Chief Financial Officer & Company SecretMr. Richard Vellacott
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.